Grivegnée A R, Autier P
Unité d'Epidémiologie et de Prévention du Cancer, Clinique de Dépistage, Institut Jules Bordet, U.L.B.
Rev Med Brux. 2001 Sep;22(4):A277-81.
In Belgium, the breast cancer screening by mammography involves a great number of women. It is largely non organized and regarded to the small number of data, it is impossible to determine if this screening is utile and if it has a good "cost-benefit" ratio. This work studies the economical aspects of breast cancer screening in the belgian healthcare system. From information found in other countries, we build four models corresponding to an organized and spontaneous screening. We studied the total processes from screening to diagnosis, including the quality assurance and the evaluation of effectiveness in the organized models. We then applied the reimbursements of the belgian health insurance in the models and compared the costs. It appears that a screening for breast cancer must be organized to give a best "cost-effectiveness" ratio. Pilot projects should be the best way to study the best organization modalities in Belgium.
在比利时,通过乳房X线摄影进行的乳腺癌筛查涉及大量女性。这一筛查在很大程度上缺乏组织,而且鉴于数据量较少,无法确定这种筛查是否有用以及是否具有良好的“成本效益”比。这项工作研究了比利时医疗体系中乳腺癌筛查的经济方面。根据在其他国家获取的信息,我们构建了四个分别对应有组织筛查和自发筛查的模型。我们研究了从筛查到诊断的整个过程,包括有组织筛查模式下的质量保证和效果评估。然后我们将比利时医疗保险的报销情况应用到这些模型中并比较成本。结果显示,乳腺癌筛查必须进行组织才能获得最佳的“成本效益”比。试点项目应该是研究比利时最佳组织模式的最佳方式。